Gene Therapy in Cystic Fibrosis
- 1 September 2001
- Vol. 120 (3) , 124S-131S
- https://doi.org/10.1378/chest.120.3_suppl.124s
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Double-Blind, Placebo Controlled, Dose Ranging Study to Evaluate the Safety and Biological Efficacy of the Lipid-DNA Complex GR213487B in the Nasal Epithelium of Adult Patients with Cystic Fibrosis. Glaxo Wellcome Research and Development Ltd., London, EnglandHuman Gene Therapy, 1998
- Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteersGene Therapy, 1997
- Complexes of Adenovirus with Polycationic Polymers and Cationic Lipids Increase the Efficiency of Gene Transfer in Vitro and in VivoJournal of Biological Chemistry, 1997
- A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, MarylandHuman Gene Therapy, 1996
- Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lungs of Nonhuman PrimatesHuman Gene Therapy, 1996
- Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor.Journal of Clinical Investigation, 1995
- Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity. University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaHuman Gene Therapy, 1994
- Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor.Journal of Clinical Investigation, 1993
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- In VivoExpression and Survival of Gene-Modified T Lymphocytes in Rhesus MonkeysHuman Gene Therapy, 1990